Highlights
- •Gastroparesis may improve with lifestyle, dietary, and pharmacologic interventions.
- •Many patients with gastroparesis may require endoscopic or surgical treatment.
- •Bariatric Surgery showed promising results when gastroparesis is associated with morbid obesity.
Abstract
Gastroparesis is a gastric motility disorder characterized by delayed gastric emptying.
It is a rare disease and difficult to treat effectively; management is a dilemma for
gastroenterologists and surgeons alike. We conducted a systematic review of the literature
to evaluate current diagnostic tools as well as treatment options. We describe key
elements in the pathophysiology of the disease, in addition to current evidence on
treatment alternatives, including nutritional considerations, medical and surgical
options, and related outcomes.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Surgery for Obesity and Related DiseasesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Control of gastric emptying and motility.Gastroenterology. 1975; 68: 804-816
- Diabetic neuropathy. General review with report of 125 cases.Medicine. 1945; 24: 111-160
- The investigation and treatment of diabetic gastroparesis.Clin Ther. 2018; 40: 850-861
- Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum).Ann Intern Med. 1958; 48: 797-812
- The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006.Gastroenterology. 2009; 136: 1225-1233
- Prevalence of hidden gastroparesis in the community: the gastroparesis "iceberg".J Neurogastroenterol Motil. 2012; 18: 34-42
- Advances in the physiology of gastric emptying.Neurogastroenterol Motil. 2019; 31e13546
- A stomach road or "Magenstrasse" for gastric emptying.J Biomech. 2007; 40: 1202-1210
- Human postprandial gastric emptying of 1-3-millimeter spheres.Gastroenterology. 1988; 94: 1315-1325
- Gastric emptying of solid radiopaque markers: studies in healthy subjects and diabetic patients.Gastroenterology. 1984; 87: 895-902
- Gastroparesis: definitions and diagnosis.Gastroenterol Clin North Am. 2015; 44: 1-7
- Clinical guideline: management of gastroparesis.Am J Gastroenterol. 2013; 108 (quiz 38): 18-37
- Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.Dig Dis Sci. 1998; 43: 2398-2404
- Similarities and differences between diabetic and idiopathic gastroparesis.Clin Gastroenterol Hepatol. 2011; 9 (quiz e133–4): 1056-1064
- What are the important subsets of gastroparesis?.Neurogastroenterol Motil. 2012; 24: 597-603
- Gastroparesis updates on pathogenesis and management.Gut Liver. 2017; 11: 579-589
- Interpreting symptoms suggesting gastroparesis in patients after gastric and esophageal surgeries.Gastroenterology. 2011; 140 (S–813)
- Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus.Neurogastroenterol Motil. 2002; 14: 123-131
- Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.Am J Physiol Endocrinol Metab. 2008; 294: E846-E852
- Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis.Gastroenterology. 1991; 100: 252-258
- Gastric emptying scintigraphy.J Nucl Med Technol. 2019; 47: 111-119
- Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms.Qual Life Res. 2004; 13: 833-844
- Assessment of gastric emptying using a low fat meal: establishment of international control values.Am J Gastroenterol. 2000; 95: 1456-1462
- Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine.J Nucl Med Technol. 2008; 36: 44-54
- Gastroparesis. Nat Rev Dis Primers. 2018; 4: 41
- Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects.Aliment Pharmacol Ther. 2008; 27: 186-196
- Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis.Neurogastroenterol Motil. 2018; 30https://doi.org/10.1111/nmo.13196
- Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients.Scand J Gastroenterol. 1994; 29: 807-813
- The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying.Br J Pharmacol. 2016; 173: 1768-1777
- Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro.Gut. 2005; 54: 1078-1084
- Relamorelin reduces vomiting frequency and severity and accelerates gastric emptying in adults with diabetic gastroparesis.Gastroenterology. 2016; 151: 87-96.e6
- Efficacy and safety of relamorelin in diabetics with symptoms of gastroparesis: a randomized, placebo-controlled study.Gastroenterology. 2017; 153: 1240-1250.e2
- Prucalopride: safety, efficacy and potential applications.Therap Adv Gastroenterol. 2012; 5: 23-30
- Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus.Diabetologia. 1989; 32: 151-159
- Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose, and glycemic control.Diabetes Care. 1997; 20: 419-423
- Do HbA1C levels correlate with delayed gastric emptying in diabetic patients?.J Neurogastroenterol Motil. 2010; 16: 414-417
- Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis.Gastroenterology. 2009; 137: 445-452
- Delayed gastric emptying is associated with early and long-term hyperglycemia in type 1 diabetes mellitus.Gastroenterology. 2015; 149: 330-339
- Glycosylated hemoglobin level may predict the severity of gastroparesis in diabetic patients.Diabetes Res Clin Pract. 2018; 135: 45-49
- The burdens, concerns, and quality of life of patients with gastroparesis.Dig Dis Sci. 2017; 62: 879-893
- Marijuana, ondansetron, and promethazine are perceived as most effective treatments for gastrointestinal nausea.Dig Dis Sci. 2020; 65: 3280-3286
- Marijuana use in patients with symptoms of gastroparesis: prevalence, patient characteristics, and perceived benefit.Dig Dis Sci. 2020; 65: 2311-2320
- Impact of cannabinoids on symptoms of refractory gastroparesis: a single-center experience.Cureus. 2019; 11e6430
- Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.Br J Pharmacol. 2004; 141: 1303-1312
- The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: pooled data from 2 randomised, double-blind, placebo controlled trials.Eur J Cancer. 2005; 41: 1278-1285
- A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.Anesth Analg. 2007; 104: 1082-1089
- A case of severe, refractory diabetic gastroparesis managed by prolonged use of aprepitant.Nat Rev Endocrinol. 2009; 5: 285-288
- Gastroparesis-associated refractory nausea treated with aprepitant.Ann Pharmacother. 2012; 46: e38
- Successful management of refractory diabetic gastroparesis with long-term aprepitant treatment.Diabet Med. 2017; 34: 1483-1486
- Aprepitant has mixed effects on nausea and reduces other symptoms in patients with gastroparesis and related disorders.Gastroenterology. 2018; 154: 65-76.e11
- 951d–Tradipitant, a novel NK-1 receptor antagonist, significantly improved nausea and other symptoms of gastroparesis: results of a multicenter, randomized, double-blind, placebo-controlled phase II trial.Gastroenterology. 2019; 156 (S-1510–1)
- Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial.JAMA. 2013; 310: 2640-2649
- Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics.Contemp Clin Trials. 2012; 33: 523-533
- Assessing pyloric sphincter pathophysiology using EndoFLIP in patients with gastroparesis.Neurogastroenterol Motil. 2015; 27: 524-531
- Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection.Gastrointest Endosc. 2019; 90: 754-760.e1
- Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation.Aliment Pharmacol Ther. 2015; 41: 360-367
- Botulinum toxin injection for treatment of gastroparesis.Gastrointest Endosc Clin N Am. 2019; 29: 97-106
- Endoscopic management of gastrointestinal motility disorders - part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.Endoscopy. 2020; 52: 498-515
- Botulinum toxin as a treatment for refractory gastroparesis: a literature review.Curr Treat Options Gastroenterol. 2018; 16: 479-488
- Endoscopic treatment of gastroparesis.World J Gastroenterol. 2015; 21: 6842-6849
- Current and emerging therapeutic options for gastroparesis.Gastroenterol Hepatol (N Y). 2018; 14: 639-645
- Novel diet, drugs, and gastric interventions for gastroparesis.Clin Gastroenterol Hepatol. 2016; 14: 1072-1080
- The role of endoscopy in gastroduodenal obstruction and gastroparesis.Gastrointest Endosc. 2011; 74: 13-21
- Safety of botulinum toxin type A: a systematic review and meta-analysis.Curr Med Res Opin. 2004; 20: 981-990
- Botulinum toxin type A inhibits rat pyloric myoelectrical activity and substance P release in vivo.Can J Physiol Pharmacol. 2007; 85: 209-214
- Epidemiology and pathophysiology of gastroparesis.Gastrointest Endosc Clin N Am. 2019; 29: 1-14
- Diabetic gastroparesis: recent insights into pathophysiology and implications for management.Expert Rev Gastroenterol Hepatol. 2013; 7: 127-139
- Botulinum toxin A improves symptoms of gastroparesis.Dig Dis Sci. 2020; 65: 1396-1404
- The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.Diabetes Care. 2004; 27: 2341-2347
- Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients.Dig Dis Sci. 2009; 54: 2634-2642
- Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.Gastrointest Endosc. 2002; 55: 920-923
- Botulinum toxin for the treatment of gastroparesis: a preliminary report.Am J Gastroenterol. 2002; 97: 1548-1552
- Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.Am J Gastroenterol. 2002; 97: 1653-1660
- Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis.Gastrointest Endosc. 2005; 61: 833-839
- Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients.Aliment Pharmacol Ther. 2006; 24: 661-667
- Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis.Aliment Pharmacol Ther. 2007; 26: 1251-1258
- Botulinum toxin A for the treatment of delayed gastric emptying.Am J Gastroenterol. 2008; 103: 416-423
- Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video).Gastrointest Endosc. 2013; 78: 764-768
- Per-oral pyloromyotomy (POP): an emerging application of submucosal tunneling for the treatment of refractory gastroparesis.Gastrointest Endosc Clin N Am. 2016; 26: 257-270
- Peroral endoscopic myotomy (POEM) for esophageal achalasia.Endoscopy. 2010; 42: 265-271
- Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video).Gastrointest Endosc. 2017; 85: 123-128
- Outcomes of per oral endoscopic pyloromyotomy in gastroparesis worldwide.World J Gastroenterol. 2019; 25: 909-922
- Technical aspects of peroral endoscopic pyloromyotomy.Gastrointest Endosc Clin N Am. 2019; 29: 117-126
- Surgical treatment of medically refractory gastroparesis in the morbidly obese.Surg Endosc. 2015; 29: 2683-2689
- Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity.Gastroenterology. 2011; 140: 101-115
- Gastric peroral endoscopic myotomy (GPOEM): a helpful tool for post laparoscopic sleeve gastrectomy gastroparesis.Obes Surg. 2021; 31: 403-404
- The effect of sleeve gastrectomy on GLP-1 secretion and gastric emptying: a prospective study.Surg Obes Relat Dis. 2017; 13: 7-14
- Impact of sleeve gastrectomy on type 2 diabetes mellitus, gastric emptying time, glucagon-like peptide 1 (GLP-1), ghrelin and leptin in non-morbidly obese subjects with BMI 30-35.0 kg/m2: a prospective study.Obes Surg. 2016; 26: 2817-2823
- How I do it: per-oral pyloromyotomy (POP).J Gastrointest Surg. 2017; 21: 1963-1968
- Enhanced recovery outcomes following per-oral pyloromyotomy (POP): a comparison of safety and cost with same-day discharge versus inpatient recovery.Surg Endosc. 2020; 34: 3153-3162
- Per-oral pyloromyotomy (POP) for medically refractory post-surgical gastroparesis.J Gastrointest Surg. 2019; 23: 1095-1103
- Laparoscopic pyloroplasty versus endoscopic per-oral pyloromyotomy for the treatment of gastroparesis.Surg Endosc. 2019; 33: 773-781
- Gastric peroral endoscopic myotomy (G-POEM) as a treatment for refractory gastroparesis: long-term outcomes.Can J Gastroenterol Hepatol. 2018; 20186409698
- Clinical efficacy of gastric per-oral endoscopic myotomy (G-POEM) in the treatment of refractory gastroparesis and predictors of outcomes: a systematic review and meta-analysis using surgical pyloroplasty as a comparator group.Surg Endosc. 2020; 34: 3352-3367
- Peroral pyloromytomy is effective and safe for postsurgical gastroparesis.J Gastrointest Surg. 2020; 24: 1417-1420
- Safety and feasibility of per-oral pyloromyotomy as augmentative therapy after prior gastric electrical stimulation for gastroparesis.J Am Coll Surg. 2019; 229: 589-595
- Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: prospective trial with assessment of pyloric function.Endoscopy. 2019; 51: 40-49
- Surgical approaches to treatment of gastroparesis: gastric electrical stimulation, pyloroplasty, total gastrectomy and enteral feeding tubes.Gastroenterol Clin North Am. 2015; 44: 151-167
- Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis.Gastrointest Endosc. 1998; 47: 67-70
- Therapeutic strategies in gastroparesis: Results of stepwise approach with diet and prokinetics, gastric rest, and PEG-J: a retrospective analysis.Neurogastroenterol Motil. 2019; 31e13588
- Percutaneous endoscopic jejunostomy in patients with gastroparesis following lung transplantation: feasibility and clinical outcome.Endoscopy. 2012; 44: 772-775
- Comparison of direct percutaneous endoscopic jejunostomy and PEG with jejunal extension.Gastrointest Endosc. 2002; 56: 890-894
- Direct percutaneous endoscopic jejunostomy: outcomes in 307 consecutive attempts.Am J Gastroenterol. 2005; 100: 2681-2688
- Long-term outcomes of direct percutaneous endoscopic jejunostomy: a 10-year cohort.Endosc Int Open. 2015; 3: E610-E614
- Systematic review and meta-analysis: gastric electrical stimulation for gastroparesis.Auton Neurosci. 2017; 202: 45-55
- Laparoscopic pyloroplasty is a safe and effective first-line surgical therapy for refractory gastroparesis.Surg Endosc. 2016; 30: 1326-1332
- Gastric bypass surgery as treatment of recalcitrant gastroparesis.Surg Obes Relat Dis. 2014; 10: 795-799
- Gastric emptying after sleeve gastrectomy: statistical evidence of a controlled prospective study with gastric scintigraphy.Minerva Chir. 2013; 68: 385-392
- Gastric electric stimulation for refractory gastroparesis.J Clin Outcomes Manag. 2019; 26: 27-38
- Gastric electrical stimulator for treatment of gastroparesis.Gastrointest Endosc Clin N Am. 2019; 29: 71-83
- Gastric electrical stimulation for gastroparesis and chronic unexplained nausea and vomiting.Curr Treat Options Gastroenterol. 2016; 14: 386-400
- Gastric electrical stimulation for medically refractory gastroparesis.Gastroenterology. 2003; 125: 421-428
- Gastric electrical stimulation: an evidence-based analysis.Ont Health Technol Assess Ser. 2006; 6: 1-79
- Laparoscopic treatment of gastroparesis: a single center experience.Surg Obes Relat Dis. 2018; 14: 200-205
- High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis.World J Surg. 2009; 33: 1693-1701
- Treatment of high-frequency gastric electrical stimulation for gastroparesis.J Gastroenterol Hepatol. 2012; 27: 1017-1026
- Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement.J Gastrointest Surg. 2011; 15: 1513-1519
- The optimal pyloric procedure: a collective review.Korean J Thorac Cardiovasc Surg. 2020; 53: 233-241
- Through-the-scope transpyloric stent placement improves symptoms and gastric emptying in patients with gastroparesis.Endoscopy. 2013; 45 (UCTN:E189–90)
- Gastric per oral endoscopic myotomy (G-POEM) for the treatment of refractory gastroparesis: early experience.Dig Dis Sci. 2018; 63: 2405-2412
- Chronic nausea and vomiting: evaluation and treatment.Am J Gastroenterol. 2018; 113: 647-659
- Pyloric dysfunction in diabetics with recurrent nausea and vomiting.Gastroenterology. 1986; 90: 1919-1925
- Pyloroplasty for refractory gastroparesis.Am Surg. 2015; 81: 738-746
- Efficacy of laparoscopic pyloroplasty for the treatment of gastroparesis.J Am Coll Surg. 2014; 218: 652-660
- Endoscopic and surgical treatments for gastroparesis: what to do and whom to treat?.Gastroenterol Clin North Am. 2020; 49: 539-556
- Tailored approach to gastroparesis significantly improves symptoms.Surg Endosc. 2018; 32: 977-982
- Minimally invasive surgical approach for the treatment of gastroparesis.Surg Endosc. 2013; 27: 61-66
- Results of completion gastrectomies in 44 patients with postsurgical gastric atony.J Gastrointest Surg. 2009; 13: 874-880
- Outcomes of surgical intervention for refractory gastroparesis: a systematic review.J Surg Res. 2018; 231: 263-269
- Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients.J Gastrointest Surg. 1999; 3 (discussion 21–3): 15-21
- End of the road for a dysfunctional end organ: laparoscopic gastrectomy for refractory gastroparesis.J Gastrointest Surg. 2015; 19: 411-417
- Surgical management of gastroparesis: gastrostomy/jejunostomy tubes, gastrectomy, pyloroplasty, gastric electrical stimulation.J Gastrointest Surg. 2013; 17: 1559-1561
- Gastric emptying of liquids and solids: roles of proximal and distal stomach.Am J Physiol. 1980; 239: G71-G76
- Patterns of abnormal gastric pacemaking after sleeve gastrectomy defined by laparoscopic high-resolution electrical mapping.Obes Surg. 2017; 27: 1929-1937
- Sleeve gastrectomy-a "food limiting" operation.Obes Surg. 2008; 18: 1251-1256
- Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy.Am J Physiol Endocrinol Metab. 2014; 306: E424-E432
- Electrical events underlying organized myogenic contractions of the guinea pig stomach.J Physiol. 2006; 576: 659-665
- Comparison study of gastric emptying after performing sleeve gastrectomy with two different techniques.Glob J Surg. 2013; 1: 53-56
- Analysis of gastric physiology after laparoscopic sleeve gastrectomy (LSG) with or without antral preservation in relation to metabolic response: a randomised study.Obes Surg. 2017; 27: 2836-2844
- Radical resection of the pyloric antrum and its effect on gastric emptying after sleeve gastrectomy.Obes Surg. 2013; 23: 567-573
- Comparative assessment of gastric emptying in obese patients before and after laparoscopic sleeve gastrectomy using radionuclide scintigraphy.Nucl Med Commun. 2015; 36: 854-862
- Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects.Obes Surg. 2009; 19: 1515-1521
- Sleeve gastrectomy: a restrictive procedure?.Obes Surg. 2007; 17: 57-62
- Gastric emptying is not affected by sleeve gastrectomy--scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum.Obes Surg. 2009; 19: 293-298
Bagloo M, Besseler M, Ude A. Sleeve gastrectomy for the treatment of diabetic gastroparesis. Proceedings 12th World Congress of Endoscopic Surgery; 2010 Apr.
Meyer A, Pallati P, Shaligran A, D. Oleynikov, Goede M. Partial longitudinal gastrectomy: a novel curative approach for gastroparesis. Proceedings of the 2012 Annual Meeting of the Society of American Gastrointestinal Endoscopic Surgeons; San Diego. 2012.
- Sleeve gastrectomy for treatment of delayed gastric emptying-indications, technique, and results.Langenbecks Arch Surg. 2020; 405: 107-116
- Time-resolved MRI after ingestion of liquids reveals motility changes after laparoscopic sleeve gastrectomy--preliminary results.Obes Surg. 2011; 21: 95-101
- Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus.Surg Obes Relat Dis. 2010; 6: 152-157
- Impact of laparoscopic sleeve gastrectomy on gastrointestinal motility.Gastroenterol Res Pract. 2018; 20184135813
- Fifth International Consensus Conference: current status of sleeve gastrectomy.Surg Obes Relat Dis. 2016; 12: 750-756
- Patient factors influence surgical options in gastroparesis.Am J Surg. 2020; 220: 1093-1097
- Long-term outcome after gastrectomy for intractable diabetic gastroparesis.Diabet Med. 2003; 20: 58-63
- Gastrectomy versus stomach left in situ with Roux-en-Y reconstruction for the treatment of gastroparesis.Surg Endosc. 2020; 34: 1847-1855
- Surgery for weight loss in adults.Cochrane Database Syst Rev. 2014; 2014: CD003641
Article info
Publication history
Published online: March 03, 2023
Accepted:
February 24,
2023
Received:
February 2,
2023
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
Published by Elsevier Inc. on behalf of American Society for Metabolic and Bariatric Surgery.
